, 2020 Subject Management’ Discussion and Analysis for the 1st Quarter in 2020 To Directors & Managers The Stock Exchange of Thailand Inter Pharma Public Company Limited (“the Company”) hereby submitting
) B.E. 2551 (2008) hereby issues the following regulations: Clause 1. In this Notification: (1) the term “company,” “parent company,” “subsidiary company,” “major shareholder,” and “controlling person
(2008) hereby issues the following regulations: Clause 1. In this Notification: (1) the term “company,” “parent company,” “subsidiary company,” “major shareholder,” and “controlling person” shall mutatis
and Exchange Act (No. 4) B.E. 2551 (2008) hereby issues the following regulations: Clause 1. In this Notification: (1) the term “company,” “parent company,” “subsidiary company,” “major shareholder
GFPT Public Company Limited Interim Management Discussion and Analysis for the 1st Quarter 2018 Page 1 of 11 Management Discussion and Analysis This interim MD&A report has been prepared based on the
GFPT Public Company Limited Interim Management Discussion and Analysis for the 1st Quarter 2020 Page 1 of 11 Management Discussion and Analysis This interim MD&A report has been prepared based on the
transaction; (2) The Company has been granted consent by the group of lending financial institutions of XPCL pursuant to the credit facilities agreements and XPCL’s parties to agreements containing a provision
(Translation) 1 Enclosure 1. Information Memorandum regarding the Connected Transaction on Engagement of CH. Karnchang Public Company Limited as the Contractor for Maintenance Services on Civil
clear, legible or audible. The provision under the first paragraph shall apply mutatis mutandis to the footnote of the advertisement. Clause 13. The securities company shall not delegate the function of